2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide

C39H48N8O4S — CID 135123860

IUPAC2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide
SMILESCCC1CN(Cc2cc([C@@H](c3ccc4c(nnn4CC)c3C)C(C)(C)NC(=O)c3cnc(N4CCC4)nc3)ccc2C)S(O)(O)c2ccccc2O1
InChIInChI=1S/C39H48N8O4S/c1-7-30-24-46(52(49,50)34-13-10-9-12-33(34)51-30)23-28-20-27(15-14-25(28)3)35(31-16-17-32-36(26(31)4)43-44-47(32)8-2)39(5,6)42-37(48)29-21-40-38(41-22-29)45-18-11-19-45/h9-10,12-17,20-22,30,35,49-50H,7-8,11,18-19,23-24H2,1-6H3,(H,42,48)/t30?,35-/m0/s1
InChIKeyOOPLFLFDDKHYQL-YBQHVXFOSA-N
MW724.93 g/mol
LogP7.11
Rot. Bonds10

About 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide

2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide (PubChem CID 135123860) has the molecular formula C39H48N8O4S and a molecular weight of 724.93 g/mol. Its IUPAC name is 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide.

Molecular Properties

Compound Name2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide
PubChem CID135123860
Molecular FormulaC39H48N8O4S
Molecular Weight724.93 g/mol
Exact Mass724.35
IUPAC Name2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide
SMILESCCC1CN(Cc2cc([C@@H](c3ccc4c(nnn4CC)c3C)C(C)(C)NC(=O)c3cnc(N4CCC4)nc3)ccc2C)S(O)(O)c2ccccc2O1
InChIInChI=1S/C39H48N8O4S/c1-7-30-24-46(52(49,50)34-13-10-9-12-33(34)51-30)23-28-20-27(15-14-25(28)3)35(31-16-17-32-36(26(31)4)43-44-47(32)8-2)39(5,6)42-37(48)29-21-40-38(41-22-29)45-18-11-19-45/h9-10,12-17,20-22,30,35,49-50H,7-8,11,18-19,23-24H2,1-6H3,(H,42,48)/t30?,35-/m0/s1
InChIKeyOOPLFLFDDKHYQL-YBQHVXFOSA-N
XLogP7.11
TPSA141.76 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms52
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500724.93
LogP ≤ 57.11
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Analyze 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide?
The IUPAC name of 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide (CID 135123860) is 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide.
What is the SMILES notation for 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide?
The canonical SMILES for 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide is CCC1CN(Cc2cc([C@@H](c3ccc4c(nnn4CC)c3C)C(C)(C)NC(=O)c3cnc(N4CCC4)nc3)ccc2C)S(O)(O)c2ccccc2O1.
What is the InChIKey of 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide?
The InChIKey is OOPLFLFDDKHYQL-YBQHVXFOSA-N. The full InChI is InChI=1S/C39H48N8O4S/c1-7-30-24-46(52(49,50)34-13-10-9-12-33(34)51-30)23-28-20-27(15-14-25(28)3)35(31-16-17-32-36(26(31)4)43-44-47(32)8-2)39(5,6)42-37(48)29-21-40-38(41-22-29)45-18-11-19-45/h9-10,12-17,20-22,30,35,49-50H,7-8,11,18-19,23-24H2,1-6H3,(H,42,48)/t30?,35-/m0/s1.
What are the key properties of 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide?
2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide has a molecular weight of 724.93 g/mol, XLogP of 7.11, 10 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(azetidin-1-yl)-N-[(1S)-1-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-1-(1-ethyl-4-methylbenzotriazol-5-yl)-2-methylpropan-2-yl]pyrimidine-5-carboxamide is sourced from PubChem (CID 135123860), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).